Jiakuan Liu
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
SPOP downregulation promotes bladder cancer progression based on cancer cell-macrophage crosstalk via STAT3/CCL2/IL-6 axis and is regulated by VEZF1.
Journal: Theranostics
Published: July 29, 2024
Identification of hexosamine biosynthesis pathway as a novel prognostic signature and its correlation with immune infiltration in bladder cancer.
Journal: Frontiers in molecular biosciences
Published: August 01, 2022
Identification of ST3GAL5 as a prognostic biomarker correlating with CD8+ T cell exhaustion in clear cell renal cell carcinoma.
Journal: Frontiers in immunology
Published: June 27, 2022
Rauwolfia vomitoria extract suppresses benign prostatic hyperplasia by inducing autophagic apoptosis through endoplasmic reticulum stress.
Journal: BMC complementary medicine and therapies
Published: December 05, 2021
PDE4B Induces Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Is Transcriptionally Suppressed by CBX7.
Journal: Frontiers in cell and developmental biology
Published: September 25, 2021
CBX7 suppresses urinary bladder cancer progression via modulating AKR1B10-ERK signaling.
Journal: Cell death & disease
Published: December 05, 2020
Pao Pereira extract suppresses benign prostatic hyperplasia by inhibiting inflammation-associated NFκB signaling.
Journal: BMC complementary medicine and therapies
Published: January 27, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026